查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600874

基因合成市场：副产品、方法、基因类型、应用和最终用途 - 2025-2030 年全球预测

Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年基因合成市场价值为42.4亿美元，预计到2024年将达到46.8亿美元，复合年增长率为10.82%，到2030年将达到87亿美元。

基因合成是指从头开始对基因序列进行酵素或化学组装。它在合成生物学中发挥着至关重要的作用，使研究人员能够为各种目的创建特定的 DNA 序列。其需求在于获得具有所需生物学特性的合成基因的过程可以比传统克隆方法显着缩短。基因合成的应用涵盖製药、农业、疫苗开发和工业生物技术等多个领域，最终用途产业利用它来进行产品开发、研究和治疗功效。

主要市场统计
基准年[2023] 42.4亿美元
预测年份 [2024] 46.8亿美元
预测年份 [2030] 87亿美元
复合年增长率（%） 10.82%

根据市场洞察，在个人化医疗需求不断增长、基因工程进步以及研发活动活性化的推动下，基因合成正处于强劲的成长轨道。合成生物学应用数量的不断增加，以及基因合成成本的下降，进一步推动了这种成长。然而，挑战仍然存在，包括伦理争议、监管复杂性以及合成基因滥用的可能性。主要限制是组装长或高度复杂基因的技术复杂性，这可能会影响成本和前置作业时间。

特别是，市场开拓庞大，包括开发新疗法和疫苗、培育抗旱作物以及提高生质燃料产量。公司可以透过投资提高合成准确性和降低错误率的技术来利用这些优势。此外，与研究机构的合作可以促进 CRISPR 基因编辑系统等应用的创新。

创新的关键领域包括开发更复杂的序列设计演算法、提高碱基对合成的准确性以及增强合成过程的扩充性以处理更大的基因序列。您可以透过解决可自订的未满足需求并将您的服务范围扩展到传统生物技术市场之外，进一步加速业务成长。因此，为了保持竞争优势，公司应该专注于提高流程效率和扩大适用性，同时改善监管环境，以解决与基因合成相关的社会和道德问题。

市场动态：揭示快速发展的基因合成市场的关键市场洞察

供需的动态交互作用正在改变基因合成市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界人口慢性病盛行率
    • 基因组研究活动的活性化和对个人化医疗的日益关注
    • 私营和公共部门增加对药物研究的投资
  • 市场限制因素
    • 基因合成的严格监管以及与该过程相关的高成本
  • 市场机会
    • 基因合成新技术的兴起
    • 基因合成在能源和农业领域的应用
  • 市场挑战
    • 合成基因的大小和复杂性的限制

波特五力：驾驭基因合成市场的策略工具

波特的五力架构是了解基因合成市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基因合成市场的外部影响

外部宏观环境因素在塑造基因合成市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因合成市场的竞争状况

对基因合成市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因合成市场供应商绩效评估

FPNV定位矩阵是评估基因合成市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界人口慢性病盛行率
      • 基因组研究活动的增加和对个人化医疗的日益关注
      • 增加私营和公共部门对药物研究的投资
    • 抑制因素
      • 基因合成的严格监管以及与该过程相关的高成本
    • 机会
      • 基因合成新技术
      • 基因合成在能源和农业产业的利用
    • 任务
      • 合成基因的大小和复杂性的限制
  • 市场区隔分析
    • 产品：扩大软体的使用范围以准确设计合成基因
    • 方式：在大型计划中增加基于晶片的综合的使用
    • 基因分型：增加快速基因合成的潜力，以便为时间敏感的计划快速获取短基因
    • 最终用途：生物技术和製药公司越来越关注创新药物发现和治疗开发
    • 基因型：为在特定宿主生物体中高水平表达而优化的表达基因的生长潜力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 基因合成市场：副产品

  • 硬体
  • 服务
    • 抗体DNA合成
    • 病毒DNA合成
  • 软体

第七章 基因合成市场：依方法分类

  • 基于晶片的合成
  • 基于PCR的酶合成
  • 固相合成

第八章以基因类型分類的基因合成市场

  • 复杂基因
  • 表达基因
  • 标准基因

第九章 基因合成市场：依应用分类

  • 疾病诊断
  • 基因/细胞疗法的发展
  • 疫苗开发

第10章基因合成市场：依最终用途

  • 学术和政府研究机构
  • 生物技术和製药公司
  • 合约调查机构

第十一章 北美和南美基因合成市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区基因合成市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东和非洲基因合成市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Evonetix 和 Analog Devices Inc 开发创新基因合成平台
    • Gyros Protein Technologies 和 Biotage 联手透过新的自动化解决方案提高胜肽精製效率
    • Synprogen 和 Gingo Bioworks 宣布计划在日本加速全球 DNA 製造和基因治疗平台服务
    • Twist Bioscience 推出 Express Genes 快速基因合成服务
    • 生技公司筹集 560 万英镑种子资金
    • 布鲁克以 1.08 亿美元收购 Phenomex
    • 系列资金支持 DNA 合成技术的扩展
    • NunaBio 筹集 190 万英镑种子资金以扩大基础设施并加速研发
    • Elegen推出ENFINIA DNA，一款促进生物经济的高速长链DNA合成仪
    • Ansa Biotechnologies 宣布成功合成新型 1005 碱基寡核苷酸
    • 金斯瑞扩大在新加坡的业务范围，提供优质基因合成服务
    • Evonetix 完成 2,400 万美元资金筹措
    • 基因合成（端到端）Barcode Biosciences 在印度启动销售
    • Eurofins Genomics Blue Heron推出IVT mRNA合成服务：基因表现的未来

公司名单

  • Biomatik Corporation
  • Biotech Desk Pvt. Ltd.
  • Twist Bioscience Corporation
  • ProteoGenix SAS
  • Creative Biogene
  • Biotage AB
  • General Biosystems, Inc.
  • Ansa Biotechnologies, Inc.
  • ProMab Biotechnologies, Inc.
  • Barcode Biosciences Private Limited
  • DNA TwoPointO Inc.
  • Elabscience Biotechnology Inc.
  • Eurofins Scientific SE
  • Telesis Bio Inc.
  • Macrogen, Inc.
  • Elegen Corp.
  • Gene Universal, Inc.
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific Inc.
  • Synbio Technologies LLC
  • Danaher Corporation
  • Constructive Bio Ltd
  • GenCefe Biotech Limited
  • NZYTech, Lda.
  • Evonetix Ltd.
  • OriGene Technologies, Inc.
  • BGI Genomics by BGI Group
  • Boster Biological Technology
  • Bioneer Corporation
  • Brooks Automation Inc.
  • QIAGEN NV
  • Agilent Technologies, Inc.
  • Merck KGaA
  • AstraZeneca PLC
  • Ginkgo Bioworks Holdings, Inc.
  • GenScript Biotech Corporation
  • Camena Bioscience
  • Azenta, Inc.
  • BioCat GmbH by AddLife AB
  • Applied Biological Materials Inc.
Product Code: MRR-3A2E844FEB5F

The Gene Synthesis Market was valued at USD 4.24 billion in 2023, expected to reach USD 4.68 billion in 2024, and is projected to grow at a CAGR of 10.82%, to USD 8.70 billion by 2030.

Gene synthesis refers to the enzymatic or chemical assembly of gene sequences from scratch. It plays a pivotal role in synthetic biology, enabling researchers to create specific DNA sequences for various purposes. Its necessity arises from its ability to expedite the process of obtaining synthetic genes with desired biological properties, which is significantly faster than traditional cloning methods. Applications of gene synthesis span multiple domains, including pharmaceuticals, agriculture, vaccine development, and industrial biotechnology, with end-use industries leveraging it for product development, research, and therapeutic efficacy.

KEY MARKET STATISTICS
Base Year [2023] USD 4.24 billion
Estimated Year [2024] USD 4.68 billion
Forecast Year [2030] USD 8.70 billion
CAGR (%) 10.82%

Market insights indicate a robust growth trajectory for gene synthesis driven by increasing demand for personalized medicine, advancements in genetic engineering, and heightened R&D activities. The rise in synthetic biology applications, alongside decreasing costs of gene synthesis, further fuels this growth. However, challenges persist, such as ethical controversies, regulatory complexities, and potential misuse of synthetic genes. A major limitation is the technical complexity involved in assembling long or highly complex genes, which can affect costs and lead time.

Opportunities in the market are vast, particularly in the development of new therapeutic drugs and vaccines, crafting drought-resistant crops, and enhancing biofuel production. Companies can capitalize on these by investing in technologies that improve synthesis accuracy and reduce error rates. Additionally, partnerships with research institutions could expedite innovations in applications like CRISPR gene-editing systems.

Key areas for innovation include developing more sophisticated algorithms for sequence design, improving base-pair synthesis accuracy, and enhancing the scalability of synthesis processes to handle larger genetic sequences. Business growth can be further accelerated by addressing the unmet needs in customizable gene synthesis and expanding service offerings to non-traditional biotech markets. Hence, for sustained competitive advantage, companies should focus on improving process efficiencies and expanding application potential, all while navigating the regulatory landscape to address societal and ethical concerns associated with gene synthesis.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Synthesis Market

The Gene Synthesis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic conditions among the global population
    • Increasing genomics research activities and rising focus on personalized medicines
    • Growing investments by the private and public sectors in pharmaceutical research
  • Market Restraints
    • Strict regulations governing gene synthesis and high cost associated with the process
  • Market Opportunities
    • Emerging new technologies in gene synthesis
    • Utilization of gene synthesis in energy and agriculture industries
  • Market Challenges
    • Limitations in size and complexity of synthetic genes

Porter's Five Forces: A Strategic Tool for Navigating the Gene Synthesis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Synthesis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Synthesis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Synthesis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Synthesis Market

A detailed market share analysis in the Gene Synthesis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Synthesis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Synthesis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Gene Synthesis Market, highlighting leading vendors and their innovative profiles. These include Biomatik Corporation, Biotech Desk Pvt. Ltd., Twist Bioscience Corporation, ProteoGenix SAS, Creative Biogene, Biotage AB, General Biosystems, Inc., Ansa Biotechnologies, Inc., ProMab Biotechnologies, Inc., Barcode Biosciences Private Limited, DNA TwoPointO Inc., Elabscience Biotechnology Inc., Eurofins Scientific SE, Telesis Bio Inc., Macrogen, Inc., Elegen Corp., Gene Universal, Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., Synbio Technologies LLC, Danaher Corporation, Constructive Bio Ltd, GenCefe Biotech Limited, NZYTech, Lda., Evonetix Ltd., OriGene Technologies, Inc., BGI Genomics by BGI Group, Boster Biological Technology, Bioneer Corporation, Brooks Automation Inc., QIAGEN N.V., Agilent Technologies, Inc., Merck KGaA, AstraZeneca PLC, Ginkgo Bioworks Holdings, Inc., GenScript Biotech Corporation, Camena Bioscience, Azenta, Inc., BioCat GmbH by AddLife AB, and Applied Biological Materials Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Hardware, Services, and Software. The Services is further studied across Antibody DNA Synthesis and Viral DNA Synthesis.
  • Based on Method, market is studied across Chip-Based Synthesis, PCR-Based Enzyme Synthesis, and Solid-Phase Synthesis.
  • Based on Gene Type, market is studied across Complex Gene, Express Gene, and Standard Gene.
  • Based on Application, market is studied across Disease Diagnosis, Gene & Cell Therapy Development, and Vaccine Development.
  • Based on End-use, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic conditions among the global population
      • 5.1.1.2. Increasing genomics research activities and rising focus on personalized medicines
      • 5.1.1.3. Growing investments by the private and public sectors in pharmaceutical research
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulations governing gene synthesis and high cost associated with the process
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging new technologies in gene synthesis
      • 5.1.3.2. Utilization of gene synthesis in energy and agriculture industries
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in size and complexity of synthetic genes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding usage of software that helps design synthetic genes accurately
    • 5.2.2. Method: Rising utilization of chip-based synthesis for large-scale projects
    • 5.2.3. Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects
    • 5.2.4. End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies
    • 5.2.5. Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Synthesis Market, by Product

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Services
    • 6.3.1. Antibody DNA Synthesis
    • 6.3.2. Viral DNA Synthesis
  • 6.4. Software

7. Gene Synthesis Market, by Method

  • 7.1. Introduction
  • 7.2. Chip-Based Synthesis
  • 7.3. PCR-Based Enzyme Synthesis
  • 7.4. Solid-Phase Synthesis

8. Gene Synthesis Market, by Gene Type

  • 8.1. Introduction
  • 8.2. Complex Gene
  • 8.3. Express Gene
  • 8.4. Standard Gene

9. Gene Synthesis Market, by Application

  • 9.1. Introduction
  • 9.2. Disease Diagnosis
  • 9.3. Gene & Cell Therapy Development
  • 9.4. Vaccine Development

10. Gene Synthesis Market, by End-use

  • 10.1. Introduction
  • 10.2. Academic & Government Research Institutes
  • 10.3. Biotechnology & Pharmaceutical Companies
  • 10.4. Contract Research Organizations

11. Americas Gene Synthesis Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Gene Synthesis Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Gene Synthesis Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Evonetix and Analog Devices Inc To Progress Revolutionary Gene Synthesis Platform
    • 14.3.2. Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency With New Automated Solution
    • 14.3.3. Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan
    • 14.3.4. Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
    • 14.3.5. Biotech Firm Closes GBP 5.6 million Seed Financing
    • 14.3.6. Bruker to Buy PhenomeX For USD 108 Million
    • 14.3.7. Series Funding to Support Expansion of DNA Synthesis Technology
    • 14.3.8. NunaBio Raises GBP 1.9M In Seed Funding To Expand Infrastructure And Accelerate R&D
    • 14.3.9. Elegen Launches ENFINIA DNA, Rapid Long DNA Synthesis to Power the Bioeconomy
    • 14.3.10. Ansa Biotechnologies Announces Successful de novo Synthesis of Oligonucleotide at 1005 Bases
    • 14.3.11. GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service
    • 14.3.12. Evonetix Closes USD 24 million Financing
    • 14.3.13. Gene Synthesis (End-to-End) Now In India At Barcode Biosciences
    • 14.3.14. Eurofins Genomics Blue Heron launches IVT mRNA Synthesis Service: The Future of Gene Expression

Companies Mentioned

  • 1. Biomatik Corporation
  • 2. Biotech Desk Pvt. Ltd.
  • 3. Twist Bioscience Corporation
  • 4. ProteoGenix SAS
  • 5. Creative Biogene
  • 6. Biotage AB
  • 7. General Biosystems, Inc.
  • 8. Ansa Biotechnologies, Inc.
  • 9. ProMab Biotechnologies, Inc.
  • 10. Barcode Biosciences Private Limited
  • 11. DNA TwoPointO Inc.
  • 12. Elabscience Biotechnology Inc.
  • 13. Eurofins Scientific SE
  • 14. Telesis Bio Inc.
  • 15. Macrogen, Inc.
  • 16. Elegen Corp.
  • 17. Gene Universal, Inc.
  • 18. Charles River Laboratories International, Inc.
  • 19. Thermo Fisher Scientific Inc.
  • 20. Synbio Technologies LLC
  • 21. Danaher Corporation
  • 22. Constructive Bio Ltd
  • 23. GenCefe Biotech Limited
  • 24. NZYTech, Lda.
  • 25. Evonetix Ltd.
  • 26. OriGene Technologies, Inc.
  • 27. BGI Genomics by BGI Group
  • 28. Boster Biological Technology
  • 29. Bioneer Corporation
  • 30. Brooks Automation Inc.
  • 31. QIAGEN N.V.
  • 32. Agilent Technologies, Inc.
  • 33. Merck KGaA
  • 34. AstraZeneca PLC
  • 35. Ginkgo Bioworks Holdings, Inc.
  • 36. GenScript Biotech Corporation
  • 37. Camena Bioscience
  • 38. Azenta, Inc.
  • 39. BioCat GmbH by AddLife AB
  • 40. Applied Biological Materials Inc.

LIST OF FIGURES

  • FIGURE 1. GENE SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 2. GENE SYNTHESIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE SYNTHESIS MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 280. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023